Life Sciences: Research
(asked on 15th September 2025) - View Source
Question to the HM Treasury:
To ask the Chancellor of the Exchequer, what steps the Treasury is taking to support the biological sciences research sector through the 10 Year UK Infrastructure strategy, published in June 2025.
This question was answered on 17th October 2025
The 10-Year Infrastructure Strategy is core to delivering the Government’s growth mission and supporting our priority growth sectors, including life sciences. The Strategy will fund at least £725 billion for infrastructure over the next decade and transform how projects are planned and delivered. This includes investment of £2.5 billion to continue delivery of East West Rail in full, enabling the growth of the Oxford to Cambridge corridor and support the world class life sciences, digital and technology sectors. In addition to the infrastructure strategy, we launched our Life Sciences Sector Plan, supported by over £2 billion of funding. The includes investing up to £600 million in the Health Data Research Service alongside Wellcome Trust, and committing up to £520 million to the Life Sciences Innovative Manufacturing Fund, supporting the UK to become a medical research powerhouse and the leading life sciences economy in Europe by 2030.
The 10-Year Infrastructure Strategy is core to delivering the Government’s growth mission and supporting our priority growth sectors, including life sciences. The Strategy will fund at least £725 billion for infrastructure over the next decade and transform how projects are planned and delivered. This includes investment of £2.5 billion to continue delivery of East West Rail in full, enabling the growth of the Oxford to Cambridge corridor and support the world class life sciences, digital and technology sectors. In addition to the infrastructure strategy, we launched our Life Sciences Sector Plan, supported by over £2 billion of funding. The includes investing up to £600 million in the Health Data Research Service alongside Wellcome Trust, and committing up to £520 million to the Life Sciences Innovative Manufacturing Fund, supporting the UK to become a medical research powerhouse and the leading life sciences economy in Europe by 2030.